Immune-mediated necrotizing myopathy: an emerging disorder
There has been an increase in the diagnosis of immune-mediated necrotizing myopathies in the last few years. The anti-HMGCR antibodies were the only detected in this sample showing their key role in the diagnosis. Early recognition of the disease facilitate to start treatment as soon as possible, which should be based on the initial response to corticosteroids and usually requires a combination of several drugs.
Authors
- Sofia Sanchez (ORCID: https://orcid.org/0000-0003-3396-4642)
- José Luís Muñoz-Blanco (ORCID: https://orcid.org/0000-0002-4354-4759)
- Antonio Sánchez‐Soblechero (ORCID: https://orcid.org/0000-0002-7098-8494)
- Irene Catalina
- Samuel López Muñoz
- Paloma Sánchez‐Mateos (ORCID: https://orcid.org/0000-0001-6589-4445)
- Alberto Lozano Ros
- Emma Sola Vendrel
Institutions
- Hospital Universitario La Paz (ES)
- Hospital General Universitario Gregorio Marañón (ES)
Publication Details
- Journal
- Neurología (English Edition)
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1016/j.nrleng.2025.09.004
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.35